Gaetano Zaccara, Luigi M Specchio

). Read article or submit your manuscript for publishing."/>
skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Long-term safety and effectiveness of zonisamide in the treatment of epilepsy: a review of the literature

Review

(2689) Views  (666) Full article downloads

Authors:

Gaetano Zaccara, Luigi M Specchio

Published Date April 2009 Volume 2009:5 Pages 249 - 259
DOI: http://dx.doi.org/10.2147/NDT.S4063

Gaetano Zaccara1, Luigi M Specchio2

1Unit of Neurology, Palagi Hospital, Firenze, Italy; 2University of Foggia, Ospedali Riuniti, Foggia, Italy

Abstract: Zonisamide (ZNS) efficacy and safety in epilepsy have been demonstrated in four double-blind, placebo-controlled studies. In the present article, we examined all long-term studies performed with this drug. Nine open-label studies, in which ZNS had been administered as an add-on or as monotherapy to epileptic patients for at least 6 months, were selected for our analysis. Four outcome measures were searched. Retention of this drug after 1 year varied between 45% and 65%. The percentages of patients achieving a 50% seizure reduction, with respect to baseline, ranged between 37% and 65%. In patients with drug-resistant forms of epilepsy, the percentage of patients reaching a 6-month seizure freedom period was 9%. The percentages of patients who discontinued the experimental drug due to adverse effects ranged between 4% and 24%. Somnolence and dizziness were the most frequently reported adverse effects. Long-term studies demonstrate that ZNS has a good efficacy and tolerability profile, and support its use as adjunctive therapy for epileptic patients.

Keywords: antiepileptic drugs, zonisamide, long-term treatment, review, epilepsy








Readers of this article also read:

Excited delirium: Consideration of selected medical and psychiatric issues
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Pregabalin in the management of partial epilepsy
Treatment of refractory complex partial seizures: role of vigabatrin
Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer’s disease
Coenzyme Q10 effects in neurodegenerative disease
Perception of risk and benefit in patient-centered communication and care
Steroid response pattern and outcome of pediatric idiopathic nephrotic syndrome: a single-center experience in northwest Iran
The relationship between deliberate self-harm behavior, body dissatisfaction, and suicide in adolescents: current concepts
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy